Stay Ahead with the Latest in Finance

Charles River Laboratories partners with X-Chem to enhance drug discovery capabilities and accelerate innovative therapeutic development.

STMicroelectronics has initiated a share repurchase program, acquiring 292,850 shares to enhance shareholder value and boost market confidence.

Construction Partners, Inc. has acquired P&S Paving to enhance its market presence and service offerings in Florida’s east coast.

RPT904 offers comparable efficacy to omalizumab with less frequent dosing, potentially improving patient compliance in allergy treatments.

Bakkt has appointed Lyn Alden, a macro strategist, to its board, enhancing its strategic focus in the digital asset industry.

Huntington Bank has completed its merger with Veritex, expanding its Texas presence and altering the competitive banking landscape.

Stifel has revised Badger Meter’s price target to $208 from $224, reflecting changing market dynamics and financial performance.

Zoliflodacin is showing promise in treating antibiotic-resistant gonorrhea, making it a crucial development in the fight against resistant infections.

Delcath Systems stock declines despite positive clinical trial results, highlighting complexities in market reactions to healthcare advancements.